Ensysce Biosciences, Inc.

ENSC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
425 Jan 8, 2020 425
425 Jan 7, 2020 CURRENT REPORT
8-K Jan 7, 2020 CURRENT REPORT
425 Jan 6, 2020 425
425 Jan 6, 2020 425
8-K Jan 6, 2020 CURRENT REPORT
425 Jan 6, 2020 CURRENT REPORT
425 Dec 31, 2019 425
8-K Dec 31, 2019 CURRENT REPORT
425 Dec 31, 2019 CURRENT REPORT
425 Dec 30, 2019 425
425 Dec 30, 2019 425
425 Dec 30, 2019 CURRENT REPORT
8-K Dec 30, 2019 CURRENT REPORT
8-K Dec 9, 2019 CURRENT REPORT
8-K Dec 3, 2019 CURRENT REPORT
10-Q Nov 7, 2019 QUARTERLY REPORT
DEF 14A Oct 28, 2019 DEFINITIVE PROXY STATEMENT
PRE 14A Oct 15, 2019 PRELIMINARY PROXY STATEMENT
10-Q Aug 7, 2019 QUARTERLY REPORT
10-Q May 7, 2019 10-Q
10-K/A Mar 12, 2019 FORM 10-K/A
10-K Mar 11, 2019 FORM 10-K
SC 13G/A Feb 15, 2019 AQR CAPITAL MANAGEMENT LLC
SC 13G/A Feb 14, 2019 AMENDMENT NO. 1
← Newer Page 20 of 23 · 551 filings Older →